Pharmaceutical, biotech, and medical device organizations are all driven with the same impetus to develop safe medical products for affecting favorable patient outcomes with improved quality of life. Achieving these results has never been more challenging than it is today.
Traditionally, pharmaceutical, biotech, and medical device companies struggle to find a preconfigured solution that fulfills all their IT needs. Instead, they have to purchase an enterprise resource planning (ERP) system and then add on industry-specific solutions to ensure they can manage every process involved in running their business, which is expensive, complicated and introduces multiple operational and compliance risks.
AX for Pharma 365™ is unrivaled in its accolades and features the robust foundation of Microsoft Dynamics 365 to empower you through your greatest challenges. Being the only ERP in the world that showcases modules specifically designed for the pharmaceutical, biotech and medical device industries, it’s able to navigate through the most complex operations. By partnering with our seasoned team, we will seamlessly implement a system that will deliver all the tools you need to transform your operations. From core ERP functions to manufacturing execution, weighing and dispensing, advanced quality management, and more, you’ll soon realize the benefits of an end-to-end solution that complements your business and scales as you grow.
Along with extensive testing and quality control to align with the requirements of the pharmaceutical, biotech, and medical device industries, AX for Pharma 365™ provides a nimble, easy, and cost-effective path for updates and validation throughout its life. Additionally, with the guarantee of conforming with regulations such as GMP, GAMP5, and FDA 21 CFR Part 11, your business will enjoy the benefits of uncompromising compliance.
Customers worldwide have chosen AX for Pharma 365™ software because they know it’s a low risk, low cost, and easily maintained solution that can be implemented quickly to transform their pharmaceutical, biotech, or medical device operations.
